Health
BIOCAD to produce liquid vaccine for COVID-19 treatment – News-Medical.Net
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a n…
Reviewed by Emily Henderson, B.Sc.Sep 25 2020
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus.
This is done in order to exclude the presence of neutralizing antibodies against the vaccine in humans and thus enhance the reliability of repeated injection. The article on …
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News17 hours agoWest End icon closes doors
-
General19 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News23 hours agoIs Auckland New Zealand’s New Cultural Capital?